| Financial Year |
March 31 2023 |
| Monetary Funds |
62,950,996,454.00 |
| Held-for-trading Financial Assets |
297,242,884.23 |
| Notes Receivable |
36,170,937,476.09 |
| Accounts Receivable |
1,841,519,264.44 |
| Advances to Suppliers |
780,387,252.33 |
| Other Receivables |
1,356,881,564.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,425,838,483.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
982,147,756.43 |
| Total Current Assets |
116,602,524,988.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,902,059,275.64 |
| Investment Properties |
6,366,037.15 |
| Fixed Assetes |
19,266,619,598.36 |
| Under-construction Projects |
1,866,138,786.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,927,425,263.47 |
| R&D expenses |
1,816,221,073.95 |
| Goodwill |
1,813,016,240.90 |
| Long-Term Deferred and Prepaid Expenses |
25,716,543.28 |
| Deferred Income Tax Assets |
3,241,159,623.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
57,506,219,783.77 |
| Total Assets |
174,108,744,771.80 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,901,303,220.66 |
| Accounts Payable |
33,490,540,476.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,333,619,601.18 |
| Taxes Payable |
1,980,780,700.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,819,586,670.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,754,257.05 |
| Other Current Liabilities |
8,325,654,370.48 |
| Sub-Total of Current Liabilities |
90,307,032,933.02 |
| Long-term Loans |
76,000,000.00 |
| Bonds Payable |
999,533,962.26 |
| Long-Term Accounts Payable |
103,353,372.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,693,180,201.90 |
| Deferred Income Tax Liabilities |
1,676,579,367.28 |
| Other Non-Current Liabilities |
927,038,995.11 |
| Sub-Total of Non-Current Liabilities |
9,984,333,235.56 |
| Total Liabilities |
100,291,366,168.58 |
| Paid-In Capital(Or Share Stock) |
9,921,799,422.00 |
| Capital Surplus |
7,963,190,075.08 |
| Surplus Reserve |
3,528,137,635.52 |
| LESS:Treasury Stock |
479,320,927.13 |
| Undistributed Profits |
48,349,692,943.86 |
| Minority Stockholder's Interest |
4,403,309,706.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
69,414,068,896.44 |
| Owner's Equity（Stockholder's Equity） |
73,817,378,603.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
174,108,744,771.80 |
